Lehrstuhl für Haut- und Geschlechtskrankheiten

Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma (2025) David P, Kouhestani D, Hansen F, Paul S, Czubayko F, Karabiber A, Weisel N, et al. Journal article Engineering Therapeutic Regulatory T Cells to Overexpress G Protein-Coupled Receptor 15 Improves Functional Fitness for In Vivo Gut Homing (2025) Müller T, Liu L, Wiesinger M, Atreya I, Atreya R, Bacher P, Becker C, et al. Journal article, Letter Discordance, accuracy and reproducibility study of pathologists' diagnosis of melanoma and melanocytic tumors (2025) Haggenmüller S, Wies C, Abels J, Winterstein JT, Heinlein L, Nogueira Garcia C, Utikal JS, et al. Journal article Loading of CAR‐T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism (2025) Pfister F, Carnell L, Löffler L, Boosz P, Schaft N, Dörrie J, Stein R, et al. Journal article Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index (2025) Kemenes S, Liu C, Schlereth M, Noversa de Sousa R, Minopoulou I, Fenzl P, Corte G, et al. Journal article Proteome Analysis of Corynebacterium diphtheriae–Macrophage Interaction (2025) Musella L, Möller J, Lischer C, Vera González J, Hofmann J, Ott L, Burkovski A Journal article Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma (2025) Muñoz Couselo E, Berking C, Baurain JF, Martelli S, Arntz R, Savoia P Journal article Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. (2025) Forschner A, Kähler KC, Gschnell M, Langan EA, Weishaupt C, Meiss F, Thoms KM, et al. Journal article Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status (2025) Placke JM, Rajcsanyi LS, Herbst R, Terheyden P, Utikal J, Pföhler C, Kreuter A, et al. Journal article Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells. (2025) Sauerer T, Bremm F, Beenen A, Heger L, Dudziak D, Bosch NC, Erdmann M, et al. Journal article